Craft

VCANBIO

Stock Price

¥21.3

2024-10-29

Market Capitalization

¥10.1 B

2024-10-29

Revenue

¥1.4 B

FY, 2025

VCANBIO Summary

Company Summary

Overview
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products. It provides precise prevention, accurate diagnosis, and cell therapy solutions.
Type
Public
Status
Active
Founded
1993
HQ
Tianjin, CN | view all locations
Website
https://www.vcanbio.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Tianjin, Tianjin HQ

    China

    No. 12, Meiyuan Road, Huayuan Industrial Zone, Binhai High-tech Zone

VCANBIO Financials

Summary Financials

Revenue (Q1, 2026)
¥312.0M
Gross profit (Q1, 2026)
¥215.4M
Net income (Q1, 2026)
¥24.2M
Cash (Q1, 2026)
¥1.6B
EBIT (Q1, 2026)
¥33.4M
Enterprise value
$8.6B

Footer menu